Potent antitumor activity of a tumor-specific soluble TCR/IL-2 fusion protein.
Belmont HJ, Price-Schiavi S, Liu B, Card KF, Lee HI, Han KP, Wen J, Tang S, Zhu X, Merrill J, Chavillaz PA, Wong JL, Rhode PR, Wong HC.
Belmont HJ, et al. Among authors: lee hi.
Clin Immunol. 2006 Oct;121(1):29-39. doi: 10.1016/j.clim.2006.05.005. Epub 2006 Jun 30.
Clin Immunol. 2006.
PMID: 16807113